Biotechnology Stocks I Performance Guide: Denali Therapeutics Inc. (DNLI)
DNLI has no dividends
Table and Chart of DNLI Performance
See what a $1,000 investment in DNLI is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DNLI Returns | |
|---|---|
| Start Date | Jan-31-2018 |
| Start Price | $23.26 |
| End Date | Dec-01-2023 |
| End Price | $18.97 |
| # Prices | 72 |
| Min Date | Jul-31-2018 |
| Min Price | $12.59 |
| Max Date | Dec-31-2020 |
| Max Price | $83.76 |
| Total Return | -18.44% |
| Annualized Return | -3.34% |
| Current Value of $1,000 Purchase | $816 |
| Number Returns | 2,556 |
| Average Return | 43.39% |
| Number Profitable Returns | 1,562 |
| Percent Profitable Returns | 61.11% |
| Number Unprofitable Returns | 994 |
| Percent Unprofitable Returns | 38.89% |
| Profitable to Unprofitable Returns Ratio | 1.57 |
| DNLI Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,621,597,000 | Price to Sales | 7.69 |
| Earnings per Share | $-0.9400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.344 |
| PRICE DATA | |
| 52 Week High | $33.31 |
| 52 Week Low | $15.45 |
| Analyst Target Price | $50.31 |
| 50-Day Moving Average | $19.61 |
| 200-Day Moving Average | $24.87 |
| FINANCIAL DATA | |
| Revenue per Share | $2.505 |
| Revenue | $340,814,000 |
| Profit Margin | -36.5% |
| Return on Equity | -0.129% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DNLI Compare Returns with S&P 500
DNLI Trendline Chart